Larisma, Rosalie C.

HRN: 29-06-72  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/01/2026
CEFTRIAXONE 1G (VIAL)
06/01/2026
06/08/2026
IV
2g
OD
HAP, Cellulitis
Checking Initial Appropriateness 

 Indication:  Empiric Then Culture-directed    Type of Infection:  PneumoniaSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines